NCT01457560View on ClinicalTrials.gov

Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio Vaccine

PHASE3CompletedINTERVENTIONAL

Enrollment

80

Participants

Timeline

Start Date

February 29, 2000

Primary Completion Date

April 30, 2001

Study Completion Date

April 30, 2001

Conditions

Hepatitis BAcellular PertussisHaemophilus Influenzae Type bDiphtheriaTetanusPoliomyelitis

Interventions

BIOLOGICAL

DTPa-HBV-IPV/Hib (Infanrix hexa™)

Three doses administered intramuscularly

BIOLOGICAL

OPV

One dose administered orally

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY